Top Markets
Coin of the day
Modalis Therapeutics Corporation Modalis Therapeutics Corporation

Modalis Therapeutics Corporation

4883
Clasificación en acciones #29676
Modalis Therapeutics Corporation focuses on discovering and developing... Modalis Therapeutics Corporation focuses on discovering and developing treatments for severe genetic conditions. The company utilizes its proprietary CRISPR-GNDM technology to create therapies by controlling gene expression through the epigenetic modulation of specific genetic loci. Modalis also has a collaborative research agreement with JCR Pharmaceuticals Co., Ltd., aimed at assessing gene therapy drug delivery methods for the central nervous system (CNS), particularly for CNS-related disorders. Founded in 2016, the company was initially known as EdiGENE Corporation before changing its name to Modalis Therapeutics Corporation in August 2019. Its operations are based in Tokyo, Japan.
Precio por acción
$0.20877985
Capitalización bursátil
$20.11M
Cambio (1 día)
-3.03%
Cambio (1 año)
-66.13%
País
JP
Comercio Modalis Therapeutics Corporation (4883)

Categoría

Historial del precio de la acción de Modalis Therapeutics Corporation (4883)
Precio más alto de cierre: $0.21 el 2026-08-01

Precio más bajo de cierre: $27.70 el 2020-08-01
Historial del precio de la acción de Modalis Therapeutics Corporation desde 2020 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2026 (TTM) 4.62%
2025 -47.79%
2024 -8.66%
2023 -67.25%
2022 -58.62%
2021 -72.31%
2020 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
$527.89 35.09%
US
$996.61 51.72%
NL
$117.42 -19.34%
AU
$740.28 6.71%
CH
$1.07K -5.58%
KR